Tumori : Impact Factor & More
eISSN: 2038-2529pISSN: 0300-8916
Share this on:
Key Metrics
CiteScore 
2.6
H-Index
56
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.54
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Tumori
Tumori Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1911 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Tumori ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Tumori
Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancer.
- 30 Jun 2026
- Tumori
End-of-life decisions and opinions: Results of E.L.D.Y.-CA.RE study carried out at Veneto Institute of Oncology, Italy.
- 30 Jun 2026
- Tumori
Quality indicators in identification and care of patients with genetic predisposition to cancer: An AIFET proposal.
- 30 Jun 2026
- Tumori
Beyond the calendar: A narrative review on chronobiological drivers of prognosis in resectable NSCLC.
- 30 Jun 2026
- Tumori
Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion.
- 30 Jun 2026
- Tumori
Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.
- 24 Jun 2026
- Tumori
Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancer.
- 30 Jun 2026
- Tumori
End-of-life decisions and opinions: Results of E.L.D.Y.-CA.RE study carried out at Veneto Institute of Oncology, Italy.
- 30 Jun 2026
- Tumori
Quality indicators in identification and care of patients with genetic predisposition to cancer: An AIFET proposal.
- 30 Jun 2026
- Tumori
Beyond the calendar: A narrative review on chronobiological drivers of prognosis in resectable NSCLC.
- 30 Jun 2026
- Tumori
Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion.
- 30 Jun 2026
- Tumori
Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.
- 24 Jun 2026
- Tumori
FAQs on Tumori
How long has Tumori been actively publishing? 
What is the publishing frequency of Tumori?
How many articles did Tumori publish last year?
What is the eISSN & pISSN for Tumori?
What is Citescore for Tumori?
What is the H Index for Tumori ?
What is SNIP score for Tumori?
What is the SJR for Tumori?
Who is the publisher of Tumori?
